title: Treatment of iatrogenic fungal infections: a black mold defines a new gray zone in medicine.
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore,Maryland, USA.
authors.forename: Shmuel
authors.initials: S
authors.lastname: Shoham
authors.forename: Kieren A
authors.initials: KA
authors.lastname: Marr
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy*; D002487:Centers for Disease Control and Prevention, U.S.; D004340:Drug Contamination; D005658:Fungi; D006801:Humans; D007049:Iatrogenic Disease; D007278:Injections, Spinal; D016921:Meningitis, Fungal / Q000188:drug therapy*; D008775:Methylprednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077555:Methylprednisolone Acetate; D011743:Pyrimidines / Q000627:therapeutic use; D012017:Referral and Consultation; D013122:Spinal Diseases / Q000188:drug therapy*; D013129:Spinal Puncture; D014230:Triazoles / Q000627:therapeutic use; D014481:United States; D065819:Voriconazole
chemical_list: D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D000077555:Methylprednisolone Acetate; D065819:Voriconazole; D008775:Methylprednisolone